Affiliation: | a From the GOLD Service, Hunter Genetics, Waratah, Australia b Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton United Kingdom c Cambridge Institute of Medical Research, University of Cambridge, Cambridge, United Kingdom d Medical Genetics, Ysbyty Gwynedd, Bangor, United Kingdom e Department of Genetic Medicine, Women’s and Children’s Hospital, Adelaide, and Departments of Paediatrics and Molecular Biosciences, University of Adelaide, Adelaide f J. C. Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood |
Abstract: | In the course of systematic screening of the X-chromosome coding sequences in 250 families with nonsyndromic X-linked mental retardation (XLMR), two families were identified with truncating mutations in BRWD3, a gene encoding a bromodomain and WD-repeat domain–containing protein. In both families, the mutation segregates with the phenotype in affected males. Affected males have macrocephaly with a prominent forehead, large cupped ears, and mild-to-moderate intellectual disability. No truncating variants were found in 520 control X chromosomes. BRWD3 is therefore a new gene implicated in the etiology of XLMR associated with macrocephaly and may cause disease by altering intracellular signaling pathways affecting cellular proliferation. |